Detalhe da pesquisa
1.
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials.
Value Health
; 26(10): 1543-1548, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422075
2.
Generating comparative evidence on new drugs and devices before approval.
Lancet
; 395(10228): 986-997, 2020 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199486
3.
Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs.
Biom J
; 58(1): 43-58, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26134089
4.
Endpoints for relative effectiveness assessment (REA) of pharmaceuticals.
Int J Technol Assess Health Care
; 30(5): 508-13, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747560
5.
Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data.
PLoS Med
; 10(10): e1001526, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24115912
6.
Secrecy or transparency? The future of regulatory trial data.
CMAJ
; 189(5): E185-E186, 2017 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28246263
7.
A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis.
BMC Rheumatol
; 6(1): 82, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482451
8.
Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data.
BMJ
; 370: m2288, 2020 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32636183
9.
Patients need better treatments, not just more of the same.
BMJ
; 382: 1466, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407080
10.
Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?
BMJ
; 380: e073100, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863730
11.
Authors' reply to Morales and Arlett.
BMJ
; 381: 740, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011919
12.
Covid-19 vaccines: individual patient data should be submitted to the European Medicines Agency.
BMJ
; 376: o417, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210257
13.
Beyond journal publications - a new format for the publication of clinical trials.
Z Evid Fortbild Qual Gesundhwes
; 120: 3-8, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28284364
14.
From publication bias to lost in information: why we need a central public portal for clinical trial data.
BMJ Evid Based Med
; 27(2): 74-76, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303480
15.
Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information.
J Eur CME
; 10(1): 1989172, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868731
16.
Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application.
PLoS One
; 11(8): e0160712, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27508415
17.
Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.
BMJ
; 350: h796, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25722024
18.
European collaboration on relative effectiveness assessments: What is needed to be successful?
Health Policy
; 119(5): 569-76, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25703539
19.
New drugs: where did we go wrong and what can we do better?
BMJ
; 366: l4340, 2019 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292109
20.
Early benefit assessment of new drugs in Germany - results from 2011 to 2012.
Health Policy
; 116(2-3): 147-53, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24472328